Crucible Therapeutics
Biotechnology Research
Overview
Crucible brings together a highly collaborative team of R&D experts and biotech entrepreneurs. With deep expertise across research, development, and commercialization, we are dedicated to advancing innovative RNA-based therapies to transform patient outcomes.
Our breakthrough treatment programmes aim to halt degenerative conditions such as Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Crucible is developing novel therapies that prevent rogue nuclear RNAs from escaping into the cytoplasm where they drive toxic gain-of-functions and cell damage. Our approach disrupts the production of toxic dipeptide repeats (DPRs) and TDP-43 aggregates, which are relevant to both C9ORF72- and Sporadic-ALS populations and potentially other neurodegenerative diseases.
Crucible Therapeutics was founded in 2023 to advance ground breaking innovations in neuroscience, originating from the Sheffield Institute for Translational Neuroscience (SITraN) and the Division of Neuroscience at the University of Sheffield, UK.
Tagline
Transformational therapies for neurodegenerative diseases
EMPLOYEES
1 employee
FOUNDED
—
HQ
—
TYPE
Privately Held
Location
- Street
- —
- City
- —
- Region
- —
- Postal code
- —
- Country
- —
Email patterns
See email patterns for Crucible Therapeutics
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
crucible-tx.com is the website of Crucible Therapeutics.
What is the industry of the company?
Crucible Therapeutics (crucible-tx.com) is in the Biotechnology Research industry.
How many employees does the company have?
Crucible Therapeutics (crucible-tx.com) has 1 employee.
What is the company type?
The company type of Crucible Therapeutics (crucible-tx.com) is Privately Held.
What are the social media accounts of the company?
The social media account of Crucible Therapeutics (crucible-tx.com) is LinkedIn.
Social media